Form 4 holding
President & CEO, Director
C4 Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,074,934
- Estimated value
- $2,031,625
- Report date
- 15 Feb 2026
- Price
- $1.89
- Ownership
- Direct
Andrew Hirsch - President & CEO, Director at C4 Therapeutics, Inc.
Issuer-level insider activity
- Role
- President & CEO, Director
- Issuer ticker
- CCCC on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Andrew Hirsch since 10 Sep 2025
Reported holdings for Andrew Hirsch in C4 Therapeutics, Inc.
Form 4 holding
President & CEO, Director
C4 Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 335,300
- Estimated value
- Report date
- 14 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Andrew Hirsch in C4 Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.